It already exists. Most brands just haven't noticed
Open any trade report and you'll find the same quiet search: skincare wants its next real antioxidant. Not surface-level protection, but something with biological depth. A compound that works at the cellular level, addresses oxidative stress, and actually reaches its target in a stable, usable form.
Here's the strange part. That molecule already exists. It's been studied in peer-reviewed literature for over two decades, its mechanism is well documented, and most cosmetic brands still haven't touched it.
It comes from hops. And it's far more interesting than its source.
The molecule: xanthohumol from hops
The compound is xanthohumol, from Humulus lupulus, the same hops used in brewing. But it isn't a novelty ingredient. It's a prenylated chalcone with one of the more complex antioxidant profiles in plant biochemistry.
- a potent scavenger of hydroxyl and superoxide free radicals
- inhibits lipid peroxidation, helping protect cell membrane integrity
- suppresses pro-inflammatory cytokines: TNF-α, IL-6, IL-1β
- inhibits tyrosinase, an enzyme central to hyperpigmentation
- reduces elastase and MMP activity, enzymes involved in the loss of skin elasticity
A 2024 review in the International Journal of Molecular Sciences, dedicated to xanthohumol in dermatology and cosmetology, confirmed this profile, including its effect on tyrosinase, elastase and MMP 1, 2 and 9, and its support for collagen and elastin expression in skin fibroblasts. The mechanism exists. The research exists. The formulation challenge is where it gets interesting.
The mechanism exists. The research exists. The molecule was never the problem.
Inflammaging: the mechanism most skincare skips
There's a concept in longevity science called inflammaging. It isn't dramatic, and it isn't visible on day one. It's persistent, low-grade inflammation that accumulates over years and quietly drives the structural breakdown of skin.
The mechanism, step by step: senescent cells build up with age and secrete pro-inflammatory cytokines (IL-1β, IL-6, IL-8, TNF-α). Those cytokines activate NF-κB signalling. NF-κB switches on matrix metalloproteinases (MMPs). MMPs degrade collagen and elastin. The visible result — wrinkles, loss of elasticity, a weaker barrier — is driven not by time alone but by chronic molecular inflammation.
A 2025 review of the skin inflammasome in the context of longevity science described how this persistent, low-grade inflammation and the senescence-associated secretory phenotype (SASP) accelerate skin aging. Most skincare treats the symptoms. Very few address the mechanism. That's the gap, and it's exactly where a functional bioactive like xanthohumol becomes interesting.
The wall every formulator hits
Xanthohumol has the antioxidant profile. It engages inflammaging pathways. It has documented activity across several mechanisms. And yet most attempts to formulate with it hit the same wall.
The molecule is highly hydrophobic, with low solubility in water. Its stability under heat and light is limited, and it can isomerise into isoxanthohumol, a structurally different compound. Without a delivery system, its bioavailability is poor. A 2024 review of xanthohumol delivery summarised the drawbacks plainly: low aqueous solubility, a short half-life, and poor bioavailability stand between a promising molecule and a working product.
And this isn't only theory or cell data. In a 2026 randomized controlled trial in humans, a formulated (micellar) xanthohumol was absorbed roughly nine times better than the native compound, regardless of dose. Direct human evidence that the delivery system, not the molecule alone, decides how much actually gets in.
So the molecule has a validated mechanism. It just doesn't arrive on its own. That's the real gap in modern formulation: not a shortage of promising compounds, but the inability to deliver them.
The active was never the problem. Getting it where it needs to go was.
Liposomal encapsulation: a delivery decision, not a marketing word
If a molecule can't reach its target alone, the question becomes how you carry it there. Liposomal encapsulation isn't new. Pharmaceutical science has used phospholipid vesicles as drug carriers for decades, precisely because they solve the problem hydrophobic compounds face.
The same logic applies to xanthohumol. Reviews of its delivery describe carrier systems, including nanoliposomes, developed specifically to improve its stability and bioavailability. What a well-built liposomal system changes:
- Stability — protection from light degradation and thermal isomerisation
- Solubility — the lipid bilayer accommodates hydrophobic molecules
- Bioavailability — vesicles interact directly with cell membranes
- Controlled release — sustained delivery over time
Pharma solved this years ago. Cosmetics are catching up. For us it was never a new direction. It's been the approach from the start, because good science needs good delivery.
Why the mechanism matters
Skin ageing is not one process. It is the cumulative result of changes happening across multiple biological systems: oxidative stress, inflammatory signalling, extracellular matrix integrity, barrier function and the skin's ability to respond and recover.
That is why skin longevity is a more interesting idea than another promise of smoother-looking skin. It shifts the question from "what can make skin look better today?" to "what biological systems help skin stay resilient, functional and capable over time?"
And that changes how we think about actives. The most interesting ingredients are not simply those that create a visible effect. They are the ones that interact with the biology underneath it, supporting cellular defence, helping regulate inflammatory signalling, protecting structural components of the skin and strengthening the systems that determine how skin responds to stress.
Appearance still matters. But in this framework, appearance becomes the visible expression of something deeper: better-supported skin biology.
Where we fit
This is where our work becomes very specific. We focus on two things: the biology of the active and the technology required to deliver it effectively.
Xanthohumol is a strong example. Its research connects it with oxidative-stress defence, inflammatory signalling and cellular protection — biological processes that sit directly inside the skin-longevity conversation. But understanding the molecule is only half of the work. The other half is giving it a form that can perform.
That is why we developed liposomal xanthohumol. Delivery technology allows us to take a highly hydrophobic active and build a system around its chemistry, improving how it is dispersed, carried and delivered across the skin barrier.
For us, skin longevity starts there: with biologically relevant actives, selected for what they can do at the mechanism level, and delivery technology designed to help more of that potential reach the skin. The cosmetic effect is what you see. The biology underneath it is what we build around.
Building a product? → Explore xanthohumol (For Brands / Contact B2B)
Just here for the science? → Read more in the Health Club
Sources
- Kołodziejczak A. et al. A Novel Look at Mechanisms and Applications of Xanthohumol (XN) in Dermatology and Cosmetology. International Journal of Molecular Sciences. 2024;25(22):11938. https://doi.org/10.3390/ijms252211938
- Antioxidants to Defend Healthy and Youthful Skin — Current Trends and Future Directions in Cosmetology. Applied Sciences. 2025;15(5):2571. https://www.mdpi.com/2076-3417/15/5/2571
- Yadav E. Inflammation and Aging: The Skin Inflammasome in the Context of Longevity Science. Journal of Cellular Immunology. 2025;7(2):37-42. Link
- Oledzka E. Xanthohumol — A Miracle Molecule with Biological Activities: A Review of Biodegradable Polymeric Carriers and Naturally Derived Compounds for Its Delivery. International Journal of Molecular Sciences. 2024;25(6):3398. https://doi.org/10.3390/ijms25063398
- Brehmer-Henkel et al. The Bioavailability of Xanthohumol in Humans and the Influence of Formulation and Dose: Randomized Controlled Trial Data. Molecular Nutrition & Food Research. 2026. https://doi.org/10.1002/mnfr.70413
